期刊文献+

非小细胞肺癌治疗反应状态的Cox分析

Assessment of response status in advanced NSCLC by Cox analysis
下载PDF
导出
摘要 目的 评价非小细胞肺癌治疗反应状态的预后价值。方法 多因素风险模型分析了 116例晚期非小细胞肺癌患者不同治疗方法及其反应状态与生存期的相关性。结果 多因素分析结果显示 ,化疗、中药、缓解状态、体重变化是生存期相关风险因子 ;单因素分析结果显示 ,治疗后达到缓解和稳定的患者生存期无差异 ,而两者生存期明显长于进展者 ,体重增加和稳定者长于体重下降者。结论 评价晚期非小细胞肺癌预后不仅依赖治疗后的肿瘤缩小 ,而且肿瘤稳定、治疗后体重变化的指标也同样重要。 Objective To assess the value of treatment response in advanced non-small cell lung cancer(NSCLC). Methods The correlation of survival to various treatment responses in 116 cases of advanced NSCLC was analyzed by using Cox proportional hazard model. Results Multivariate analysis showed that chemotherapy, Chinese herbal medicine, response status of the tumor and loss of body weight were risk factors. Univariate analysis showed that there were no significant differences in survival between the cases with the tumors showing response to treatment or remaining stable, but the survival here was significantly longer than in the progressive cases. The survival was significantly longer in the patients putting on body weight than in those losing weight. Conclusion The prognosis of advanced NSCLC depends not only on the reduction of tumor size, but also on its stableness and the gaining of body weight.
出处 《徐州医学院学报》 CAS 2001年第6期431-433,共3页 Acta Academiae Medicinae Xuzhou
基金 国家中医药管理局资助项目 (0 0 - 0LP0 2 )
关键词 非小细胞肺癌 治疗 预后 COX模型 lung tumor, non-small cell lung cancer therapy, response status to progresis
  • 相关文献

参考文献9

  • 1李广灿,叶召.全球常见恶性肿瘤的当前流行趋势[J].肿瘤防治研究,1999,26(4):308-312. 被引量:17
  • 2Anderson H, Hopwood P, Stephens RJ, et al. Gemcitsbine plus best supportive care(BSC) vs BSC in inoperable non - small cell lung cancer-a randomized trial with quality of life as the primary outcome [J]. BrJ Cancer, 2000,83(4):447-453.
  • 3Breathnach OS, Freidlin B, Conley B, et al. Twenty - two years of phase Ⅲ trials for patients with advanced non - small -cell lung cancer: sobering results[J]. J Clin Oncol, 2001,19(6): 1734 - 1742.
  • 4李佩文,张代钊,郝迎旭,崔惠娟,罗兰,于莉莉,李凯鹏,郤凤兰.平肺方治疗非小细胞肺癌109例临床观察[J].中医杂志,1995,36(2):87-88. 被引量:46
  • 5骆福添.Cox回归的危险度指标与生存率估计[J].中国肿瘤,2000,9(3):102-104. 被引量:3
  • 6DeWysW. Management of cancer cachexia[J]. Semin Oncol,1985,12(4) :452 - 460.
  • 7GebbiaA, TestaA ,GebbiaN. Prospective randomized trial of two dose levels of megestrol acetate in the management of anorexia - cachexia syndrome in patients with metastatic cancer[J]. Br J Cancer,1996,73(12): 1576 - 1580.
  • 8高桥丰.消化器癌血行性转移治疗としての血管新生抑制—tumor dormant therapy[J].医学のぁゅみ,1998,184(13):917-920.
  • 9Cesano A, Lane SR, Ross GA, et al . Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non - small cell lung cancer patients[J]. Int J Oncol,2000,17(3) :587- 590.

二级参考文献6

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部